Back to ETFs
EquityBIB
ProShares Ultra Nasdaq Biotechnology
Ticker
BIB
Asset Class
Equity
Assets Under Management
87.33M
Issuer
ProShares
Expense Ratio
95.00%
Inception Date
06-04-2010
Dividend Yield
0.74%
About This Fund
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
ProShares Ultra Nasdaq Biotechnology Price Chart
Loading chart…